Tech Innovation Framework
Research checked: 17 October 2026. The Tech Innovation Framework (TIF) supports modern core GP electronic patient record systems within DSIC. NHS England's pages, updated 13 October 2026, confirm an extension to 30 September 2027 while the replacement framework develops. 111, 112
The system role
TIF expects six minimum functions: patient information, appointments, consultations, prescribing, referrals and resource management. This is the core GP EPR role. The broader DSIC model also supports other products, but that does not make TIF a general framework for any adjunct application. 112
Its published architecture emphasises public-cloud hosting, browser access, public internet connectivity, CIS2 authentication and open APIs. It also describes the API Management direction for new FHIR v4 integrations. These are scoped requirements and development directions, not evidence that every existing interface has migrated to FHIR R4. 112
A product's generic cloud or FHIR support is therefore insufficient to establish TIF compliance. The actual foundation functions and relevant assurance evidence remain necessary.
From framework entry to clinical use
NHS England's assurance explanation separates national-service interoperability, six core capabilities and eleven overarching standards. Clinical assessment includes test-lab work and review of safety evidence. Clinical Authority to Release (CATR) is a named clinical release decision in that process. 117
| Evidence to distinguish | What it can establish |
|---|---|
| Framework appointment | A commercial position within the framework. |
| Capability and standards assessment | Evidence about the assessed product and requirements. |
| Clinical release | A release decision within the stated clinical assurance process. |
| Catalogue availability | The solution's published purchasing position. |
| Local migration and deployment | Whether the intended organisation can safely operate the implemented service. |
This table is an explanatory separation of evidence, not a replacement for the official onboarding process. A supplier's status at one point does not prove that all later activities are complete.
The assurance page also examines migration mappings, missing or unmapped data, initial-load comparisons and clinical walkthroughs of medicines and allergies. Its description of weekend pilots does not guarantee a weekend migration for every practice. The page was last edited 11 November 2025; do not treat its supplier-status table as a newly issued October 2026 decision. 117
A bounded practice example
A published practice case study illustrates migration, testing and training. Its reported benefits are attributed local experience, not a general guarantee or Defence implementation. 124
For COPPER TIGER, this example supports examining the human work around a system change: testing with clinicians, preparing users and checking migrated records. It does not establish a Defence implementation or settle the proposed lifelong-record design.
Relationship to the planned replacement
TIF's extension provides commercial continuity while the Digital Primary Care Open Framework develops. The planned framework separately identifies foundation EPR, clinical and operational support, and R&D lots. Its future tender must establish the applicable requirements. TIF's architecture and assurance process are useful comparators, but cannot simply be copied into every new lot. 109, 112
Neither the extension nor the planned go-live date establishes every incumbent call-off expiry, migration deadline or supplier's appointment to the successor. The procurement timetable does not determine the Defence target architecture.
Independent research
Read the current TIF page, assurance explanation and practice case study. Use the migration guide within its established-supplier scope. Record source dates separately from retrieval dates and distinguish appointment, assurance, release and local use.
Continue with the planned Digital Primary Care Open Framework to examine the proposed successor, its three lots and the limits of the procurement evidence.